Quantler is a blockchain for creating, analysing, sharing and running of decentralized structured investment products. Create structured products (such as an ETF) in equities or cryptocurrencies using themes. As there are a lot of the tokenized products being launched (currently over 1 900 available) the structured products for these assets are lacking behind (such as sector-based ETFs). Using Quantler’s blockchain anyone can create structured products (for regular assets such as Equities and cryptocurrencies) and run them on a decentralized network (much like smart contracts). Quantler also allows for regular assets, for this market Quantler’s solution is more flexible and has a lower costs base (targeted for exchanges, family offices and investment managers). The QUANT token’s intrinsic value is dependent on the AUM (asset under management) by the entire network. Quantler is like a Vanguard or BlackRock, but then in the form of a network.

We intend to develop MeconCash into a platform that allows user’s assets to be transferred and traded between different types of services by integrating point reward systems, contents purchase, and settlement, which are currently operated separately between existing services and those under development. To that end, we will build the reward and settlement system, develop the API to connect it with other services, and build an ecosystem that can be used in the on- and off-line real economy. All this will ensure the usability, connectivity, and sustainability of MeconCash. We will develop a variety of mobile-based applications, games, and contents on the platform and link it with such services as online marketplaces where users can purchase products. The reward system used by a service generally invalidates the rewards owned by users when the service is terminated. MeconCash, however, can transform the rewards obtained from using our services into valuable assets. As such, users will be able to fulfill the demand for new services with MeconCash even when the services they use are terminated, make transactions between them, and use the assets in the real economy. We will stabilize the MeconCash ecosystem by developing new blockchain-based businesses and linking it with external services which already exists. Additionally, MeconCash will be available in 70% of ATMs in Korea so that users can directly withdraw MeconCash to fiat money.

DexBerry is a next-generation decentralized ecosystem Mega-Application backed by a revolutionary smart contract technology. The Mission of DexBerry is to leverage ever-evolving blockchain technologies to provide users with an application that supports easy access to cross-chain liquidity and tools for fast, easy, and secure acquisition of digital assets without moving from one project feature to another. With DexBerry, users can Analyze, Advertise, Acquire, Create, Compete, Earn, Game, Launch, Swap & more without moving 1 INCH.

Zillios is the next generation international real estate platform, revolutionary and highly innovative. Zillios completely changes the way the real estate market operates providing a state of the art scalable infrastructure to all key stakeholders, including smart contract based features to tackle current inefficiencies in rental and buying processes. Blockchain-based property transfer is foreseen in Zillios´ technology providing a future-proof infrastructure.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.